Genomic Prediction
3 known investors
Find your way into Genomic Prediction
Sign up to see every warm intro you have to Genomic Prediction
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genomic Prediction team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LifeView, operated by Genomic Prediction, offers preimplantation genetic testing (PGT) for IVF embryos, including screening for aneuploidy, monogenic disorders, structural rearrangements, and polygenic disease risk. Its tests serve fertility clinics and IVF patients to help select embryos for transfer.
Investors · 3
AAF Management Ltd.listed by AAF Management Ltd.Washington
How we know: AAF Management Ltd.'s portfolio page · the VCSheet dataset · Not right? Tell us
Metaplanetlisted by MetaplanetTallinn · $500K – $10M
How we know: Metaplanet's portfolio page · the VCSheet dataset · Not right? Tell us
Founder mafia
3 people who came through Genomic Prediction went on to found or lead other companies.
Frequently asked questions
- What does Genomic Prediction do?
- LifeView, operated by Genomic Prediction, offers preimplantation genetic testing (PGT) for IVF embryos, including screening for aneuploidy, monogenic disorders, structural rearrangements, and polygenic disease risk. Its tests serve fertility clinics and IVF patients to help select embryos for transfer.
- Who are Genomic Prediction's investors?
- Genomic Prediction's investors include AAF Management Ltd., Metaplanet, Western Technology Investment.






